Cantourage Group SE (ETR:HIGH)
Germany
· Delayed Price · Currency is EUR | Market Cap | 64.59M |
| Revenue (ttm) | 1.96M |
| Net Income (ttm) | 221.14K |
| Shares Out | 12.47M |
| EPS (ttm) | n/a |
| PE Ratio | 292.10 |
| Forward PE | 39.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,828 |
| Average Volume | 10,746 |
| Open | 4.590 |
| Previous Close | 4.550 |
| Day's Range | 4.590 - 4.800 |
| 52-Week Range | 3.500 - 8.550 |
| Beta | -0.49 |
| RSI | 62.63 |
| Earnings Date | Oct 31, 2025 |
About Cantourage Group SE
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany. [Read more]
Financial Performance
In 2023, Cantourage Group SE's revenue was 1.66 million, an increase of 175.55% compared to the previous year's 603,307. Earnings were 38,679, an increase of 329.10%.
Financial StatementsNews
EQS-Adhoc: Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 2025 - for the first time more than EUR 10.7 million revenue in one month
EQS-Ad-hoc: Cantourage Group SE / Key word(s): Development of Sales/Quarterly / Interim Statement Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 2025 - for the first time ...
EQS-News: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 – for the first time more than EUR 10.7 million revenue in one month
EQS-News: Cantourage Group SE / Key word(s): Development of Sales/Quarterly / Interim Statement Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 – for the first time more than EUR 1...